UNSPSC 51151523: Distigmine

Commodity

Code facts

NIGP codes
1

UNSPSC codes and definitions come from the UN Development Programme (managed by GS1 US), and state and local contract opportunities from the governments' procurement sites.

NIGP codes for 51151523

Definition

This classification denotes a cholinesterase inhibitor with the molecular formula C22H32N4O4, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier T940307O7B, chemically known as 3,3-(1,6-hexanediylbis((methylimino)carbonyl)oxy)bis(1-methylpyridinium) dibromide but generally known as distigmine, which bears US NIH Compound Identifier 27522. European Medicines Agency schedules Distigmine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB01797MIG.

Read the full definition

World Health Organization schedules distigmine in its Anatomical Therapeutic Chemical (ATC) Classification. DISTIGMINE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. As of Q4 2014, DISTIGMINE remains the US FDA Preferred Term for this commodity. SMILES: BR.BR.O(C(=O)N(CCCCCCN(C)C(=O)OC1C[N](CCC1)C)C)C1C[N](CCC1)C..

About UNSPSC 51151523

UNSPSC 51151523 Distigmine is a Commodity code that captures pharmaceutical products purchased by state and local health agencies, though the recent opportunities tagged under it span naloxone procurement and direct-to-manufacturer prescription programs rather than distigmine specifically. State and local governments buying under this code are primarily county health departments and state health and human services commissions seeking emergency medical supplies and prescription-fulfillment solutions. The Seminole County, Florida IFB for naloxone and drug deactivation systems exemplifies the emergency-response product category, while the Texas Health and Human Services Commission's RFI on direct-to-manufacturer prescriptions signals growing interest in alternative pharmacy supply-chain models that bypass traditional pharmacy benefit managers and wholesalers.

Recent activity centers on Florida and Texas. Seminole County posted IFB 60459723LAS on June 30, 2026, seeking 1,900 units of naloxone and 800 safe drug deactivation systems annually with quarterly deliveries to its Community Health Building in Sanford, with a response deadline of July 26, 2023, and a two-year initial term plus one-year renewal option. The Texas Health and Human Services Commission issued RFI HHS0017013 on April 3, 2026, to gather vendor capabilities for implementing direct pharmaceutical manufacturer relationships outside traditional PBM and GPO channels, seeking responses on contracting flexibility, negotiated net pricing models, and outcomes-based agreement capability. Neither opportunity specifies explicit set-aside or disadvantaged-enterprise designations, though the Seminole County procurement includes FEMA-compliance requirements and standard federal environmental regulations.

Quick answers

What is UNSPSC 51151523?

UNSPSC 51151523 is Distigmine, a commodity in UNSPSC 51000000, Pharmaceutical Products incl. Contraceptives and Vaccines.

Which NIGP codes match UNSPSC 51151523?

UNSPSC 51151523 maps to 1 NIGP code, 26912 Autonomic Drugs.

On GovTribe

See everything under UNSPSC 51151523

  • State & local contract opportunities, awards and contract vehicles under this code
  • Contacts who buy under this code
  • Ask GovTribe AI about this code